↓
 

Tag Archives: molecular marker testing

Dr. Vince Miller, on the Weighty Decision of a Move to Industry, the Barriers to Molecular Marker Testing, and Disrupting the Pricing of Cancer Therapies | BTJ-018

Hosts Jack West and Charu Aggarwal meet with Dr. Vince Miller to discuss the process of deciding to move from academia to industry, the evolution of molecular marker testing, and the potential for EQRx to break the impasse of escalating cancer drug costs. (42:53)

Audio Podcast

Dr. Charu Aggarwal (Part 1): Growing Momentum for Plasma-Based NGS Testing in Advanced NSCLC

Dr. West & Charu Aggarwal from University of Pennsylvania reviews data from her own group & other centers, demonstrating increasing practical utility & remaining limitations of liquid biopsy testing for molecular markers in advanced NSCLC. (26:52)

Research Question or Standard of Care: The Barriers to Broad Adoption in Cancer Care (BMIC-013)

Dr. Jack West reviews the key differences between findings that are worthy of clinical research and those that should be broadly adopted as a standard of care in cancer treatment, and differences in practice in academic vs. community practice. (10:03)

Download MP3 Audio Version

↑